NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) (“NRx Pharmaceuticals”, (NRx), a clinical-stage biopharmaceutical company today announced that it …
![NRx Pharmaceuticals Keynote - "Ketamine for Suicidal Depression"](https://i0.wp.com/globalpharmalive.com/wp-content/uploads/2024/01/pexels-alex-green-5699864.jpg?resize=760%2C427&ssl=1)
![NRx Pharmaceuticals Keynote - "Ketamine for Suicidal Depression"](https://i0.wp.com/globalpharmalive.com/wp-content/uploads/2024/01/pexels-alex-green-5699864.jpg?resize=760%2C427&ssl=1)
Pharma News From Around The World
Pharma News From Around The World
Pharma News From Around The World
NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) (“NRx Pharmaceuticals”, (NRx), a clinical-stage biopharmaceutical company today announced that it …
NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) (“NRx Pharmaceuticals”, the “Company”), a clinical-stage biopharmaceutical company, today announced that …
Johnson & Johnson announced today the submission of a supplemental Biologics License Application (sBLA) to …
Mabwell (688062.SH), an innovative biopharmaceutical company with entire industry chain, announced that the new drug …
Shanghai Henlius Biotech, Inc. (2696. HK) announced that the new drug application (NDA) for new …